- Home
- MEGL vs HSDT Comparison
MEGL vs HSDT Comparison
Compare MEGL & HSDT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MEGL
- HSDT
- Stock Information
- Founded
- MEGL 2016
- HSDT N/A
- Country
- MEGL Hong Kong
- HSDT United States
- Employees
- MEGL N/A
- HSDT N/A
- Industry
- MEGL Finance: Consumer Services
- HSDT Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- MEGL Finance
- HSDT Health Care
- Exchange
- MEGL Nasdaq
- HSDT Nasdaq
- Market Cap
- MEGL 6.8M
- HSDT 6.4M
- IPO Year
- MEGL 2022
- HSDT N/A
- Fundamental
- Price
- MEGL $1.51
- HSDT $13.26
- Analyst Decision
- MEGL
- HSDT Hold
- Analyst Count
- MEGL 0
- HSDT 1
- Target Price
- MEGL N/A
- HSDT N/A
- AVG Volume (30 Days)
- MEGL 104.3K
- HSDT 1.4M
- Earning Date
- MEGL 10-29-2025
- HSDT 11-11-2025
- Dividend Yield
- MEGL N/A
- HSDT N/A
- EPS Growth
- MEGL N/A
- HSDT N/A
- EPS
- MEGL N/A
- HSDT N/A
- Revenue
- MEGL $1,645,862.00
- HSDT $295,000.00
- Revenue This Year
- MEGL N/A
- HSDT N/A
- Revenue Next Year
- MEGL N/A
- HSDT $75.13
- P/E Ratio
- MEGL N/A
- HSDT N/A
- Revenue Growth
- MEGL N/A
- HSDT N/A
- 52 Week Low
- MEGL $1.02
- HSDT $5.37
- 52 Week High
- MEGL $5.52
- HSDT $1,200.00
- Technical
- Relative Strength Index (RSI)
- MEGL 49.29
- HSDT 50.45
- Support Level
- MEGL $1.45
- HSDT $13.10
- Resistance Level
- MEGL $1.65
- HSDT $25.50
- Average True Range (ATR)
- MEGL 0.13
- HSDT 3.11
- MACD
- MEGL -0.01
- HSDT 0.05
- Stochastic Oscillator
- MEGL 30.95
- HSDT 38.18
About MEGL Magic Empire Global Limited
Magic Empire Global Ltd is a financial services provider in Hong Kong which principally engage in the provision of corporate finance advisory services and underwriting services. The companys offerings mainly comprise of IPO sponsorship services, Financial advisory and independent financial advisory services, Compliance advisory services, Underwriting services, Corporate service.
About HSDT Helius Medical Technologies Inc. (DE)
Helius Medical Technologies Inc is a neurotech company focused on neurological wellness. The company's purpose is to develop, license, or acquire non-invasive technologies targeted at reducing symptoms of neurological disease or trauma. The company's product, known as the Portable Neuromodulation Stimulator (PoNS) is authorized for sale in Canada as a class II, a non-implantable medical device intended for use as a short-term treatment of gait deficit due to symptoms from multiple sclerosis and balance deficit due to mild-to-moderate traumatic brain injury and is to be used in conjunction with supervised therapeutic exercise.